-
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.
The effect of early aggressive antihypertensive treatment on kidney function in diabetic nephropathy was studied prospectively in ten insulin-dependent diabetics (mean age 29 years). During the mean pretreatment period of 29 (range 23-38) months the glomerular filtration rate (GFR) decreased significantly and the urinary albumin excretion rate and arterial blood pressure rose significantly. During the 39 month (range 28-48) period of antihypertensive treatment with metoprolol, hydralazine, and frusemide (furosemide) or thiazide, arterial blood pressure fell from 144/97 mm Hg (mean of all pretreatment values) to 128/84 mm Hg (mean of all post-treatment values), urinary albumin excretion from 977 micrograms/min to 433 micrograms/min, and GFR from 80 to 62 ml/min/1 . 73 m2. The rate of decline in GFR decreased from 0.91 ml/min/month before treatment to 0.39 ml/min/month (range 0.08 to 0.68 ml/min/month) during treatment.
PMID: 6133986 [PubMed - indexed for MEDLINE]
-
Cited by 21 PubMed Central articles
-
Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.
de Boer IH, Kestenbaum B, Rue TC, Steffes MW, Cleary PA, Molitch ME, Lachin JM, Weiss NS, Brunzell JD, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group.
Arch Intern Med. 2008 Sep 22; 168(17):1867-73.
[Arch Intern Med. 2008]
-
ReviewTherapeutic strategies to slow chronic kidney disease progression.
Wühl E, Schaefer F.
Pediatr Nephrol. 2008 May; 23(5):705-16. Epub 2008 Mar 12.
[Pediatr Nephrol. 2008]
-
Progression of kidney disease in type 2 diabetes - beyond blood pressure control: an observational study.
Leehey DJ, Kramer HJ, Daoud TM, Chatha MP, Isreb MA.
BMC Nephrol. 2005 Jun 28; 6(1):8. Epub 2005 Jun 28.
[BMC Nephrol. 2005]
- » See all...